RYVU THERAPEUTICS ZY-,40/ PLSELVT00013 /
2024-06-06 8:21:24 AM | Chg. -0.1200 | Volume | Bid5:30:01 PM | Ask6:55:03 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
12.3000EUR | -0.97% | 0 Turnover: 0.0000 |
12.0000Bid Size: 60 | 13.2400Ask Size: 60 | 290.89 mill.EUR | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -4.00 PLN | -13.04% |
EPS Diluted: | - PLN | -13.04% |
Revenues per Share: | 2.91 PLN | -21.93% |
Book Value per Share: | 11.23 PLN | -39.98% |
Cash Flow per Share: | -3.66 PLN | - |
Dividend per Share: | - PLN | - |
Total | in th. | |
Revenues: | 67,296.00 PLN | -1.67% |
Net Income: | -92,112.00 PLN | 9.94% |
Operating Cash Flow: | -84,550.00 PLN | - |
Cash and Cash Equivalents: | 57,939.00 PLN | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 18.55 | 19.75 |
P/BV ratio: | 4.81 | 5.12 |
P/CF Ratio: | -14.77 | -15.72 |
PEG: | 1.04 | - |
Earnings Yield: | -7.41% | -6.96% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 290.89 mill. EUR | 306.04 mill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | - EUR | - EUR |
Shares Outstanding: | 23.12 mill. |
Profitability
Gross Profit Margin: | - |
EBIT Margin: | -150.01% |
Net Profit Margin: | -136.88% |
Return on Equity: | -35.48% |
Return on Assets: | -22.85% |
Financial Strength
Liquidity I / Cash Ratio: | 83.12% |
Liquidity II / Quick Ratio: | 130.23% |
Liquidity III / Current Ratio: | 399.40% |
Debt / Equity Ratio: | 55.32% |
Dynam. Debt / Equity Ratio: | -169.85% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - PLN |
Revenues / Employee: | - PLN |
Net Income / Employee: | - PLN |
Total Assets / Employee: | - PLN |
* Fiscal Year End: | 2023-12-31 |
Accounting Standard: | IFRS |
Currency: | PLN |